Urine C-peptide creatinine ratio is a noninvasive alternative to the mixed-meal tolerance test in children and adults with type 1 diabetes

Diabetes Care

Volumn 34, Issue 3, 2011, Pages 607-609

  Besser, Rachel E J ^a   Ludvigsson, Johnny ^b   Jones, Angus G ^a   Mcdonald, Timothy J ^a,c   Shields, Beverley M ^a   Knight, Bridget A ^a   Hattersley, Andrew T ^a  

^a PENINSULA MEDICAL SCHOOL   (United Kingdom)

^b LINKÖPING UNIVERSITY   (Sweden)

^c ROYAL DEVON AND EXETER NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; CREATININE; INSULIN;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; CHILD; CONTROLLED STUDY; CORRELATION COEFFICIENT; DIABETIC PATIENT; DISEASE DURATION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; INSULIN TOLERANCE TEST; MAJOR CLINICAL STUDY; MIXED MEAL TOLERANCE TEST; NON INVASIVE MEASUREMENT; POSTPRANDIAL STATE; PROTEIN URINE LEVEL; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; TEST MEAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; C-PEPTIDE; CREATININE; DIABETES MELLITUS, TYPE 1; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 79956067719     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc10-2114     Document Type: Article

References (13)

1. Greenbaum CJ, Mandrup-Poulsen T, McGee PF, et al.; Type 1 Diabetes Trial Net Research Group; European C-Peptide Trial Study Group. Mixed-meal tolerance test versus glucagon stimulation test for the assessment of beta-cell function in therapeutic trials in type 1 diabetes. Diabetes Care 2008;31:1966-1971
2. Clark PM. Assays for insulin, proinsulin(s) and C-peptide. Ann Clin Biochem 1999;36:541-564 (Pubitemid 29410707)
3. Steffes MW, Sibley S, Jackson M, Thomas W. Beta-cell function and the development of diabetes-related complications in the diabetes control and complications trial. Diabetes Care 2003;26:832-836 (Pubitemid 36929351)
4. Palmer JP, Fleming GA, Greenbaum CJ, et al. C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve beta-cell function: report of an ADA workshop, 21-22 October 2001. Diabetes 2004;53:250-264 (Pubitemid 38044724)
5. Ryan EA, Paty BW, Senior PA, et al. Five-year follow-up after clinical islet transplantation. Diabetes 2005;54:2060-2069 (Pubitemid 40911269)
6. Hattersley A, Bruining J, Shield J, Njolstad P, Donaghue K; International Society for Pediatric and Adolescent Diabetes. ISPAD Clinical Practice Consensus Guidelines 2006-2007. The diagnosis and management of monogenic diabetes in children. Pediatr Diabetes 2006;7:352-360
7. McDonald TJ, Knight BA, Shields BM, Bowman P, Salzmann MB, Hattersley AT. Stability and reproducibility of a single-sample urinary C-peptide/creatinine ratio and its correlation with 24-h urinary C-peptide. Clin Chem 2009;55:2035-2039
8. The Diabetes Control and Complications Trial Research Group. Effect of intensive therapy on residual beta-cell function in patients with type 1 diabetes in the diabetes control and complications trial. A randomized, controlled trial. Ann Intern Med 1998;128:517-523
9. Aurbach-Klipper J, Sharph-Dor R, Heding LG, Karp M, Laron Z. Residual B cell function in diabetic children as determined by urinary C-peptide. Diabetologia 1983;24:88-90 (Pubitemid 13191884)
10. Gjessing HJ, Matzen LE, Frøland A, Faber OK. Correlations between fasting plasma C-peptide, glucagon-stimulated plasma C-peptide, and urinary C-peptide in insulin-treated diabetics. Diabetes Care 1987;10:487-490 (Pubitemid 17125012)
11. Koskinen P, Viikari J, Irjala K, Kaihola HL, Seppälä P. Plasma and urinary C-peptide in the classification of adult diabetics. Scand J Clin Lab Invest 1986;46:655-663 (Pubitemid 17171517)
12. Huttunen NP, Knip M, Käär ML, Puukka R, Akerblom HK. Clinical significance of urinary C-peptide excretion in children with insulin-dependent diabetes mellitus. Acta Paediatr Scand 1989;78:271-277 (Pubitemid 19079577)
13. Sasaki N, Miyamoto S, Niimi H, Nakajima H. C-peptide/creatinine ratio in early morning urine as an indicator of residual B-cell function in insulin-dependent diabetes. Acta Paediatr Jpn 1991;33:375-380